Treatment-focused wellness and metabolic care

Vyora Wellness review

Vyora combines weight-care support with a separate NAD+ and sermorelin menu. Consider the service for one defined care need; the breadth of the catalog does not establish a prevention membership or a proven healthy-lifespan benefit.

A useful next step?

Consider the purpose, the care relationship and the full commitment.

Visit Vyora WellnessOfficial provider website. No affiliate relationship is currently listed.

A reason to consider it

Readers who want a treatment-specific clinical relationship and can identify which support and charges belong to that plan.

  • Separate product pages identify NAD+, sermorelin and injectable weight-care prices.
  • The homepage names nutrition education and guided movement resources.
  • Clinical approval and refund stages are described.

What deserves scrutiny

Buyers treating several wellness prescriptions as a comprehensive healthspan plan or assuming every product includes the same GLP-1 resources.

  • Catalog breadth does not establish a combined membership or universal testing package.
  • Product-specific support and supplied quantities still need confirmation.
  • A later approved refund may be account credit rather than cash.
In this review

Start with one care need rather than a wellness stack

Vyora lists NAD+ and sermorelin injections separately from its compounded semaglutide and tirzepatide programs. The menu is broad, but the useful purchase is a specific clinical relationship with a reason for treatment. Adding more products is not itself a more complete healthy-aging plan. [1] [2] [3]

I would choose by the decision the clinician needs to make and the follow-up it requires. An energy concern, a weight-care prescription and a preventive measurement have different jobs. A combined wellness label does not show that they belong in the same plan or that buying several preparations improves healthy lifespan.

The support description is useful only when it belongs to the selected plan

The homepage names nutrition education from Sammi Williams and a guided three-phase movement program from Tess Redish. Those are concrete GLP-1 member resources. They do not establish recurring individual appointments or prove that every NAD+ or sermorelin purchase includes the identical package. Confirm what accompanies the actual treatment. [1]

Likewise, a general care-team promise does not identify the responsible prescriber, scheduled monitoring or assigned pharmacy. The terms distinguish independent clinical providers and third-party pharmacies from the platform and name VIOS as a pharmacy contact. That is not confirmation of the dispenser or batch for an individual prescription. Establish those roles before adding a recurring treatment. [6]

Keep each price attached to its own product and calendar

NAD+ and sermorelin each list $189 per month. The injectable semaglutide and tirzepatide pages list $299 and $399, with four-week subscription descriptions. Those figures are separate offers, not one membership invoice. Shipping and applicable fees also require confirmation in the selected plan. [1] [2] [3] [4] [5]

The shipping policy describes dispatch every three weeks for monthly subscriptions, sometimes two days early. Billing follows the selected recurring frequency. Do not infer a three-week charging cycle or a universal supplied amount from that schedule. A complete budget needs the actual prescription supply and first and future payments together. [7]

The refund boundary matters before adding another treatment

Provider denial during review earns a full refund to the original payment method. Other approved refunds generally become account credit, with a $50 review deduction after the approved prescription is sent to the pharmacy. Filled and dispensed prescriptions are final. A credit may be useful for an ongoing member, but it does not free the same money to seek care elsewhere. [8]

FDA does not approve compounded medicines before marketing. A biological mechanism or a community testimonial cannot establish a healthy-lifespan result for these preparations. Choose one justified treatment and useful support after the commitment is clear. If the unresolved need is preventive testing or ordinary primary care, compare that targeted service before buying a wider medication menu. [9]

Understanding the cost

NAD+ and sermorelin each list $189/month; injectable semaglutide/tirzepatide $299/$399 with four-week descriptions. These are separate offers, not a combined membership bill. Confirm supply, actual recurring interval, included support, shipping and fees; refund form depends on approval and fulfillment status.

Build your cost estimate

Sources

  1. Vyora: current clinical care, expanded nutrition and movement support descriptions
  2. Vyora: NAD+ injection price, provider review and evidence limits
  3. Vyora: sermorelin injection offer and compounded-product disclosure
  4. Vyora: semaglutide four-week subscription and promotional conditions
  5. Vyora: tirzepatide four-week subscription and clinician-directed care
  6. Vyora: independent clinical roles, cash-pay responsibility and subscription addendum
  7. Vyora: processing after approval, three-week dispatch schedule and delivery estimates
  8. Vyora: original-payment refunds, account credits, review fee and cancellation
  9. FDA: compounded medicines and the limits of premarket review

This review evaluates public service information. It does not claim patient enrollment, product testing or measurement of clinical outcomes.

Affiliate partner

Before you go

Explore this option
Continue to your original choiceWe may earn a commission if you choose our partner. These services may differ in products, fees and clinical access.